Nanomaterials supported by polymers for tissue engineering applications: A review

F Habibzadeh, SM Sadraei, R Mansoori… - Heliyon, 2022 - cell.com
In the biomedical sciences, particularly in wound healing, tissue engineering, and
regenerative medicine, the development of natural-based biomaterials as a carrier has …

Chitosans and nanochitosans: recent advances in skin protection, regeneration, and repair

PG Ferreira, VF Ferreira, FC da Silva, CS Freitas… - Pharmaceutics, 2022 - mdpi.com
Chitosan displays a dual function, acting as both an active ingredient and/or carrier for
pharmaceutical bioactive molecules and metal ions. Its hydroxyl-and amino-reactive groups …

Advances in chitosan-based drug delivery systems: A comprehensive review for therapeutic applications

A Haider, S Khan, DN Iqbal, M Shrahili, S Haider… - European Polymer …, 2024 - Elsevier
Chitosan (CS), a biocompatible and biodegradable polymer produced from chitin, has
attracted interest in drug delivery due to its unique properties and diverse applications. Over …

Chitosan for biomedical applications, promising antidiabetic drug delivery system, and new diabetes mellitus treatment based on stem cell

SI Othman, AM Alturki, GM Abu-Taweel… - International Journal of …, 2021 - Elsevier
Since chitosan's excellent pharmacokinetic and chemical properties, it is an attractive and
promising carbohydrate biopolymer in biomedical applications. Chitosan's beneficial …

Nanocarriers for treatment of dermatological diseases: principle, perspective and practices

AK Ramanunny, S Wadhwa, M Gulati, SK Singh… - European Journal of …, 2021 - Elsevier
Skin diseases are the fourth leading non-fatal skin conditions that act as a burden and affect
the world economy globally. This condition affects the quality of a patient's life and has a …

The novel treatments based on tissue engineering, cell therapy and nanotechnology for cutaneous leishmaniasis

Z Abpeikar, M Safaei, AA Alizadeh, A Goodarzi… - International Journal of …, 2023 - Elsevier
Cutaneous leishmaniasis (CL) is a global public health issue. Conventional treatments have
substantial costs, side effects, and parasite resistance. Due to easy application and …

[HTML][HTML] In vitro and in vivo assessment of a non-animal sourced chitosan scaffold loaded with xeno-free umbilical cord mesenchymal stromal cells cultured under …

A Di Nubila, MN Doulgkeroglou, M Gurdal… - Biomaterials and …, 2024 - Elsevier
There is an increasing demand to not only accelerate the development of advanced therapy
tissue engineered medicines, but to also eliminate xenogeneic materials from their …

Nanomedicine-based strategies to improve treatment of cutaneous leishmaniasis

N Goonoo, MA Laetitia Huët… - Royal Society …, 2022 - royalsocietypublishing.org
Nanomedicine strategies were first adapted and successfully translated to clinical
application for diseases, such as cancer and diabetes. These strategies would no doubt …

Immunomodulatory effects of bee pollen on doxorubicin‐induced bone marrow/spleen immunosuppression in rat

F Shaldoum, AF El‐Kott, MMA Ouda… - Journal of food …, 2021 - Wiley Online Library
This study investigated the immunomodulatory effects of Bee Pollen (BP) on Doxorubicin
(DOX)‐induced bone marrow/spleen suppression in rats. 48 Wistar rats were divided into 6 …

Chitosan-based nanomaterials as valuable sources of anti-leishmanial agents: a systematic review

HI AlMohammed, A Khudair Khalaf, A E. Albalawi… - Nanomaterials, 2021 - mdpi.com
Background: The current chemotherapy agents against various forms of leishmaniasis have
some problems and side effects, including high toxicity, high cost, and the emergence of …